Literature DB >> 17175002

Exploring the contribution of distal P4 promoter elements to the oncoselectivity of Minute Virus of Mice.

Justin Paglino1, Erik Burnett, Peter Tattersall.   

Abstract

Minute Virus of Mice (MVM) shares inherent oncotropic properties with other members of the genus Parvovirus. Two elements responsible, at least in part, for this oncoselectivity have been mapped to an Ets1 binding site adjacent to the P4 TATA box of the initiating promoter, P4, and to a more distal cyclic AMP responsive element (CRE), located within the telomeric hairpin stem. Here the CRE overlaps one half-site for the binding of parvoviral initiation factor (PIF), which is essential for viral DNA replication. We used a degenerate oligonucleotide selection approach to show that CRE binding protein (CREB) selects the sequence ACGTCAC within this context, rather than its more generally accepted palindromic TGACGTCA recognition site. We have developed strategies for manipulating these sequences directly within the left-end palindrome of the MVM infectious clone and used them to clone mutants whose CRE either matches the symmetric consensus sequence or is scrambled, or in which the PIF binding site is incrementally weakened with respect to the CRE. The panel of mutants were tested for fitness relative to wildtype in normal murine fibroblasts A9 or transformed human fibroblasts 324 K, through multiple rounds of growth in co-infected cultures, using a differential real-time quantitative PCR assay. We confirmed that inactivating the CRE substantially abrogates oncoselectivity, but found that improving its fit to the palindromic consensus is somewhat debilitating in either cell type. We also confirmed that reducing the PIF half-site spacing by one basepair enhances oncoselectivity, but found that a further basepair deletion significantly reduces this effect.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17175002      PMCID: PMC1853334          DOI: 10.1016/j.virol.2006.11.006

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  34 in total

1.  cis requirements for the efficient production of recombinant DNA vectors based on autonomous parvoviruses.

Authors:  J Kestler; B Neeb; S Struyf; J Van Damme; S F Cotmore; A D'Abramo; P Tattersall; J Rommelaere; C Dinsart; J J Cornelis
Journal:  Hum Gene Ther       Date:  1999-07-01       Impact factor: 5.695

2.  Activation of promoter P4 of the autonomous parvovirus minute virus of mice at early S phase is required for productive infection.

Authors:  L Deleu; A Pujol; S Faisst; J Rommelaere
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

3.  Parvovirus initiation factor PIF: a novel human DNA-binding factor which coordinately recognizes two ACGT motifs.

Authors:  J Christensen; S F Cotmore; P Tattersall
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

4.  Prostate attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigen-positive prostate cancer cells.

Authors:  R Rodriguez; E R Schuur; H Y Lim; G A Henderson; J W Simons; D R Henderson
Journal:  Cancer Res       Date:  1997-07-01       Impact factor: 12.701

5.  Dose-dependent regression of HeLa cell-derived tumours in SCID mice after parvovirus H-1 infection.

Authors:  S Faisst; D Guittard; A Benner; J Y Cesbron; J R Schlehofer; J Rommelaere; T Dupressoir
Journal:  Int J Cancer       Date:  1998-02-09       Impact factor: 7.396

6.  Upstream CREs participate in the basal activity of minute virus of mice promoter P4 and in its stimulation in ras-transformed cells.

Authors:  M Perros; L Deleu; J M Vanacker; Z Kherrouche; N Spruyt; S Faisst; J Rommelaere
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

7.  ras oncogene-dependent activation of the P4 promoter of minute virus of mice through a proximal P4 element interacting with the Ets family of transcription factors.

Authors:  F Fuks; L Deleu; C Dinsart; J Rommelaere; S Faisst
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

8.  Two new members of the emerging KDWK family of combinatorial transcription modulators bind as a heterodimer to flexibly spaced PuCGPy half-sites.

Authors:  J Christensen; S F Cotmore; P Tattersall
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

9.  A novel cellular site-specific DNA-binding protein cooperates with the viral NS1 polypeptide to initiate parvovirus DNA replication.

Authors:  J Christensen; S F Cotmore; P Tattersall
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

Review 10.  Replication-selective oncolytic viruses in the treatment of cancer.

Authors:  Bart Everts; Henk G van der Poel
Journal:  Cancer Gene Ther       Date:  2005-02       Impact factor: 5.987

View more
  5 in total

1.  Several cis-elements including a palindrome involved in pollen-specific activity of SBgLR promoter.

Authors:  Peng Zhou; Fang Yang; Jingjuan Yu; Guangming Ao; Qian Zhao
Journal:  Plant Cell Rep       Date:  2010-03-10       Impact factor: 4.570

2.  Maintenance of the flip sequence orientation of the ears in the parvoviral left-end hairpin is a nonessential consequence of the critical asymmetry in the hairpin stem.

Authors:  Lei Li; Susan F Cotmore; Peter Tattersall
Journal:  J Virol       Date:  2012-08-29       Impact factor: 5.103

3.  Distinct host cell fates for human malignant melanoma targeted by oncolytic rodent parvoviruses.

Authors:  Ellen M Vollmers; Peter Tattersall
Journal:  Virology       Date:  2013-08-09       Impact factor: 3.616

4.  LuIII parvovirus selectively and efficiently targets, replicates in, and kills human glioma cells.

Authors:  Justin C Paglino; Koray Ozduman; Anthony N van den Pol
Journal:  J Virol       Date:  2012-05-02       Impact factor: 5.103

Review 5.  Structure and function of the parvoviral NS1 protein: a review.

Authors:  Qianqian Xie; Jigui Wang; Chenchen Gu; Jing Wu; Weiquan Liu
Journal:  Virus Genes       Date:  2022-10-17       Impact factor: 2.198

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.